Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment.
MDSC (myeloid-derived suppressor cell)
NK cells
cancer
innate immune cells
innate lymphoid cells (ILC)
macrophages
tissue-resident immune cells
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
03
2022
accepted:
03
05
2022
entrez:
27
6
2022
pubmed:
28
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
Cancer immunotherapy has led to impressive advances in cancer treatment. Unfortunately, in a high percentage of patients is difficult to consistently restore immune responses to eradicate established tumors. It is well accepted that adaptive immune cells, such as B lymphocytes, CD4
Identifiants
pubmed: 35757002
doi: 10.3389/fcell.2022.907572
pii: 907572
pmc: PMC9221069
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
907572Informations de copyright
Copyright © 2022 Busà, Bulati, Badami, Zito, Maresca, Conaldi, Ercolano and Ianaro.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Head Neck. 2000 Jan;22(1):64-70
pubmed: 10585607
Clin Immunol. 2007 Nov;125(2):184-93
pubmed: 17827069
Front Immunol. 2019 Jan 21;9:3176
pubmed: 30719026
EBioMedicine. 2017 Aug;22:58-67
pubmed: 28754304
Cell. 2014 Apr 10;157(2):340-356
pubmed: 24725403
Oncotarget. 2015 Sep 8;6(26):22857-68
pubmed: 25762633
Nat Rev Immunol. 2008 Jan;8(1):59-73
pubmed: 18097448
Cell Mol Immunol. 2014 Sep;11(5):495-502
pubmed: 24813230
Cell. 2016 Jan 28;164(3):365-77
pubmed: 26806130
Nat Rev Immunol. 2020 Jan;20(1):7-24
pubmed: 31467405
Clin Cancer Res. 2010 Jul 1;16(13):3420-30
pubmed: 20570927
Nature. 2007 Oct 4;449(7162):564-9
pubmed: 17873860
Nat Rev Drug Discov. 2007 Aug;6(8):662-80
pubmed: 17667957
Sci Signal. 2016 Sep 27;9(447):ra94
pubmed: 27678219
Biomaterials. 2021 Nov;278:121137
pubmed: 34560422
J Immunol. 2004 Jun 15;172(12):7335-40
pubmed: 15187109
Ther Adv Med Oncol. 2019 Jun 21;11:1758835919854238
pubmed: 31258629
Front Cell Dev Biol. 2021 Dec 23;9:740827
pubmed: 35004667
Cancer Res. 2011 Aug 15;71(16):5412-22
pubmed: 21708957
Front Immunol. 2019 May 16;10:1114
pubmed: 31156651
Blood. 2007 Apr 1;109(7):2871-7
pubmed: 17164341
Onco Targets Ther. 2016 Sep 23;9:5855-5866
pubmed: 27713639
J Exp Med. 2005 Oct 17;202(8):1075-85
pubmed: 16230475
Immunity. 2013 Apr 18;38(4):792-804
pubmed: 23601688
Clin Cancer Res. 2016 Dec 1;22(23):5661-5672
pubmed: 27178742
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20729-20740
pubmed: 32796104
Front Immunol. 2020 Jul 30;11:1680
pubmed: 32849585
Nat Commun. 2021 May 5;12(1):2538
pubmed: 33953160
J Cancer Res Clin Oncol. 2012 Aug;138(8):1427-32
pubmed: 22692855
Clin Breast Cancer. 2021 Feb;21(1):e63-e73
pubmed: 32893093
Cell Mol Immunol. 2020 Jan;17(1):1-12
pubmed: 31611651
BMB Rep. 2021 Jan;54(1):31-43
pubmed: 33298246
J Exp Med. 2012 Apr 9;209(4):653-60
pubmed: 22430490
Int J Mol Sci. 2021 Jun 29;22(13):
pubmed: 34209703
J Immunother Cancer. 2020 Nov;8(2):
pubmed: 33158916
Cancer Res. 2011 Aug 15;71(16):5423-34
pubmed: 21697280
PLoS Biol. 2018 Oct 17;16(10):e2005264
pubmed: 30332405
Eur J Haematol. 2014 Aug;93(2):96-102
pubmed: 24617663
Nat Med. 2018 Aug;24(8):1178-1191
pubmed: 29942093
Annu Rev Pathol. 2020 Jan 24;15:123-147
pubmed: 31530089
J Immunol. 2019 Jan 1;202(1):171-182
pubmed: 30504420
Cancer Res. 2014 Sep 15;74(18):5057-69
pubmed: 25082815
Prostate. 2010 Mar 1;70(4):443-55
pubmed: 19902470
J Immunother Cancer. 2021 Oct;9(10):
pubmed: 34667078
Oncotarget. 2016 Jul 19;7(29):46301-46314
pubmed: 27317770
Cell Immunol. 2004 Aug;230(2):99-108
pubmed: 15598425
EMBO J. 2022 Jun 14;41(12):e109300
pubmed: 35467036
Nat Immunol. 2010 Nov;11(11):1030-8
pubmed: 20935648
Science. 2011 Jan 7;331(6013):44-9
pubmed: 21212348
Cancer Res. 2012 Oct 15;72(20):5428-9; author reply 5430
pubmed: 23047870
Cell. 2018 Dec 13;175(7):1731-1743.e13
pubmed: 30503213
Mol Immunol. 2021 Aug;136:161-167
pubmed: 34171565
Nat Med. 2011 Aug 28;17(9):1094-100
pubmed: 21873989
J Exp Med. 2011 Sep 26;208(10):1989-2003
pubmed: 21930769
Sci Transl Med. 2015 Apr 15;7(283):283ra55
pubmed: 25877893
Int J Mol Sci. 2013 Nov 07;14(11):22022-41
pubmed: 24213603
Annu Rev Immunol. 2013;31:563-604
pubmed: 23516985
Cancer Cell. 2009 Aug 4;16(2):91-102
pubmed: 19647220
J Exp Med. 2003 Jul 7;198(1):173-81
pubmed: 12847141
Oncoimmunology. 2016 Dec 7;6(1):e1264562
pubmed: 28197391
Science. 2016 May 20;352(6288):aad3018
pubmed: 27199435
Cancer Res. 2015 Sep 1;75(17):3479-91
pubmed: 26269531
Nat Rev Immunol. 2013 Feb;13(2):145-9
pubmed: 23348417
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344
Mol Immunol. 2010 May;47(9):1765-73
pubmed: 20347150
Cancer Res. 2008 Oct 15;68(20):8437-45
pubmed: 18922917
Cell Death Differ. 2008 Feb;15(2):226-33
pubmed: 17541426
Cancer Discov. 2019 Jun;9(6):694-695
pubmed: 31160329
Cell. 2017 Mar 9;168(6):1086-1100.e10
pubmed: 28283063
Immunity. 2013 Jan 24;38(1):79-91
pubmed: 23273845
Sci Rep. 2020 Dec 3;10(1):21194
pubmed: 33273652
Cancer Sci. 2010 May;101(5):1326-30
pubmed: 20331633
Immunity. 2014 Jul 17;41(1):21-35
pubmed: 25035951
Nat Med. 2007 Jul;13(7):828-35
pubmed: 17603493
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Br J Haematol. 2003 Aug;122(4):617-22
pubmed: 12899717
Nat Immunol. 2021 Jul;22(7):851-864
pubmed: 34099918
Front Immunol. 2020 May 21;11:924
pubmed: 32508825
Cancer Immunol Res. 2019 Jul;7(7):1162-1174
pubmed: 31088844
Annu Rev Immunol. 2005;23:275-306
pubmed: 15771572
Front Oncol. 2018 Mar 12;8:49
pubmed: 29594035
Front Immunol. 2015 Jun 25;6:330
pubmed: 26124761
Blood. 2013 Jan 17;121(3):423-30
pubmed: 23100308
J Leukoc Biol. 2020 Aug;108(2):723-737
pubmed: 32017245
Oncotarget. 2016 May 10;7(19):28697-710
pubmed: 26885690
Nat Rev Immunol. 2008 Aug;8(8):594-606
pubmed: 18641647
Nature. 2020 Mar;579(7797):130-135
pubmed: 32076273
Cell Res. 2020 Jul;30(7):562-563
pubmed: 32367040
Cancer Cell. 2016 Aug 8;30(2):324-336
pubmed: 27424807
Cancer Immunol Immunother. 2016 Feb;65(2):161-9
pubmed: 26728481
J Exp Med. 2002 Jun 3;195(11):1499-505
pubmed: 12045248
Clin Cancer Res. 2014 Jul 1;20(13):3581-8
pubmed: 24727324
Clin Cancer Res. 2013 Aug 1;19(15):4079-91
pubmed: 23785047
Cancer Immunol Res. 2015 Dec;3(12):1344-55
pubmed: 26253731
J Exp Med. 2002 Mar 4;195(5):637-41
pubmed: 11877486
Cancer Res. 2018 Oct 15;78(20):5891-5900
pubmed: 30104241
Nat Commun. 2016 Mar 29;7:11150
pubmed: 27021436
Nature. 2016 Jun 01;534(7607):396-401
pubmed: 27281205
Curr Pharm Des. 2004;10(8):893-8
pubmed: 15032692
Signal Transduct Target Ther. 2021 Oct 7;6(1):362
pubmed: 34620838
Nat Immunol. 2013 Oct;14(10):978-85
pubmed: 24048119
Haematologica. 2015 Jul;100(7):e257-60
pubmed: 25710455
Am J Transplant. 2004 Oct;4(10):1614-27
pubmed: 15367216
Cancer Immunol Immunother. 2021 Aug;70(8):2401-2410
pubmed: 33511454
J Immunol. 2010 Aug 15;185(4):2273-84
pubmed: 20644162
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Front Immunol. 2019 Dec 03;10:2801
pubmed: 31849977
Adv Cancer Res. 2001;82:107-31
pubmed: 11447761
Cells. 2019 Dec 23;9(1):
pubmed: 31878087
J Investig Allergol Clin Immunol. 2022 Apr 12;:0
pubmed: 35416152
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Nat Rev Immunol. 2012 Mar 22;12(4):239-52
pubmed: 22437937
J Immunol. 1998 Jun 15;160(12):5729-34
pubmed: 9637481
Eur J Cancer. 2017 Nov;86:285-295
pubmed: 29059634
Elife. 2017 Dec 12;6:
pubmed: 29231815
Int J Cancer. 2004 May 10;109(6):893-9
pubmed: 15027123
Immunol Cell Biol. 2012 Jan;90(1):109-15
pubmed: 21383766
J Exp Med. 2011 Sep 26;208(10):2005-16
pubmed: 21930765
Lancet Oncol. 2017 Dec;18(12):e731-e741
pubmed: 29208439
J Immunother Cancer. 2019 Mar 4;7(1):62
pubmed: 30832732
Int J Mol Sci. 2020 May 20;21(10):
pubmed: 32443699
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818764499
pubmed: 29558872
PLoS One. 2009 Aug 10;4(8):e6562
pubmed: 19668347
Clin Cancer Res. 2017 Jan 1;23(1):137-148
pubmed: 27354473
Cancer Res. 2013 Aug 1;73(15):4629-40
pubmed: 23722543
Front Immunol. 2019 Apr 03;10:656
pubmed: 31024531
Eur J Cancer. 2021 Oct 9;158:17-26
pubmed: 34638090
Cancer Cell. 2013 Feb 11;23(2):249-62
pubmed: 23410977
J Exp Med. 2011 Sep 26;208(10):1949-62
pubmed: 21930770
Cancer Immunol Res. 2020 Apr;8(4):556-564
pubmed: 32019778
J Immunol. 2000 Dec 1;165(11):6037-46
pubmed: 11086035
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6742-7
pubmed: 19346489
Semin Immunol. 2017 Jun;31:20-29
pubmed: 28888619
Blood. 2009 Mar 12;113(11):2498-507
pubmed: 19056691
J Clin Invest. 2018 Jun 1;128(6):2356-2369
pubmed: 29708510
Front Immunol. 2020 Nov 16;11:554880
pubmed: 33329513
Cancer Sci. 2008 Oct;99(10):2028-36
pubmed: 19016763
Immunol Lett. 2010 Jan 4;127(2):150-6
pubmed: 19895848
Cancer Res. 2005 Apr 1;65(7):2964-71
pubmed: 15805300
Nat Rev Immunol. 2014 Feb;14(2):94-108
pubmed: 24445665
Science. 2010 Feb 5;327(5966):656-61
pubmed: 20133564
Mol Med Rep. 2015 Jul;12(1):760-8
pubmed: 25695487
Cancer Cell. 2010 Feb 17;17(2):121-34
pubmed: 20138013
Nat Med. 2020 Jun;26(6):878-885
pubmed: 32451495
Immunity. 2015 Apr 21;42(4):607-12
pubmed: 25902480
Breast. 2003 Jun;12(3):172-8
pubmed: 14659323
Immunity. 2017 Aug 15;47(2):323-338.e6
pubmed: 28813661
Cell Death Dis. 2016 Jul 28;7(7):e2312
pubmed: 27468688
Oncogene. 2021 Jul;40(27):4521-4537
pubmed: 34120141
Blood Cancer J. 2015 Jul 31;5:e328
pubmed: 26230952
Exp Hematol. 2008 Apr;36(4):464-72
pubmed: 18261838
Oncoimmunology. 2021 Mar 29;10(1):1900508
pubmed: 33854820
Immunology. 2006 Mar;117(3):386-95
pubmed: 16476058
Nat Rev Immunol. 2002 Mar;2(3):151-61
pubmed: 11913066
Cancer Discov. 2016 Aug;6(8):870-85
pubmed: 27179037
Nat Med. 2013 Oct;19(10):1264-72
pubmed: 24056773
Nat Commun. 2017 Sep 19;8(1):593
pubmed: 28928446
Semin Immunol. 2014 Apr;26(2):127-31
pubmed: 24548893
Invest New Drugs. 2013 Jun;31(3):760-8
pubmed: 22907596
Oncotarget. 2017 Dec 7;8(70):114554-114567
pubmed: 29383101
Sci Rep. 2015 Jul 17;5:10752
pubmed: 26182859
Adv Cancer Res. 2008;101:277-348
pubmed: 19055947
Oncotarget. 2017 Mar 21;8(31):50582-50593
pubmed: 28881585
Cancer Immunol Immunother. 2013 May;62(5):909-18
pubmed: 23589106
Oncoimmunology. 2013 Dec 1;2(12):e26968
pubmed: 24498562
J Exp Clin Cancer Res. 2017 Apr 13;36(1):53
pubmed: 28407783
Adv Ther. 2016 Jul;33(7):1055-71
pubmed: 27234989
Oncoimmunology. 2015 Jan 22;4(4):e1001224
pubmed: 26137398
PLoS One. 2010 Jun 25;5(6):e11311
pubmed: 20593019
Cell. 2016 Mar 10;164(6):1198-1211
pubmed: 26967286
J Transl Med. 2011 Jun 09;9:90
pubmed: 21658270
Front Immunol. 2018 Oct 30;9:2499
pubmed: 30425715
Clin Immunol. 2018 Feb;187:76-84
pubmed: 29061445
Clin Cancer Res. 2010 May 15;16(10):2769-80
pubmed: 20460472
J Mol Biol. 1990 Jul 5;214(1):281-97
pubmed: 2370666
Eur J Immunol. 1996 Oct;26(10):2487-92
pubmed: 8898964
Med Oncol. 2013 Mar;30(1):482
pubmed: 23377987
Nat Commun. 2019 Mar 29;10(1):1405
pubmed: 30926812
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):10094-10099
pubmed: 30232256
Nat Rev Clin Oncol. 2018 Apr;15(4):234-248
pubmed: 29405201
Cancer Res. 2012 Oct 15;72(20):5188-97
pubmed: 22836755
J Exp Med. 2018 Oct 1;215(10):2536-2553
pubmed: 30201786
Trends Immunol. 2011 Aug;32(8):364-72
pubmed: 21752715
Front Immunol. 2017 Apr 10;8:387
pubmed: 28443091
J Biomed Sci. 2015 Oct 15;22:85
pubmed: 26471060
Front Immunol. 2019 Aug 29;10:2078
pubmed: 31555287
Nat Immunol. 2012 May 27;13(7):667-73
pubmed: 22634866
Br J Pharmacol. 2012 Dec;167(7):1533-49
pubmed: 22817659
Cancers (Basel). 2020 Mar 28;12(4):
pubmed: 32231116
J Immunol. 2006 Jun 1;176(11):6752-61
pubmed: 16709834
PLoS One. 2011;6(6):e20702
pubmed: 21695190
Cancer Biomark. 2015;15(4):425-32
pubmed: 25792471
Nat Rev Cancer. 2017 Dec;17(12):709-724
pubmed: 29059149
J Leukoc Biol. 2012 Sep;92(3):673-82
pubmed: 22636320
J Biol Chem. 2002 Jun 14;277(24):21123-9
pubmed: 11950832
Iran J Immunol. 2019 Dec;16(4):291-298
pubmed: 31885006
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43
pubmed: 16344461
Front Immunol. 2019 May 03;10:949
pubmed: 31130949
Mol Cancer Ther. 2017 Aug;16(8):1544-1554
pubmed: 28572167
Cytometry B Clin Cytom. 2018 May;94(3):392-399
pubmed: 29244250
Oncoimmunology. 2014 Aug 03;3(8):e952197
pubmed: 25610741
Oncoimmunology. 2012 Sep 1;1(6):974-975
pubmed: 23162776
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
Cancer Discov. 2021 Jan;11(1):34-44
pubmed: 33277307
Cancer Res. 2010 Jan 1;70(1):68-77
pubmed: 20028852
Clin Cancer Res. 2004 Nov 15;10(22):7466-74
pubmed: 15569976
PLoS One. 2013 Nov 04;8(11):e78049
pubmed: 24223759
J Immunol. 2006 Dec 1;177(11):7833-40
pubmed: 17114454
Nat Immunol. 2018 Jul;19(7):723-732
pubmed: 29915296
J Oncol. 2019 Feb 28;2019:4508794
pubmed: 30941175
Cancer Res. 2003 Oct 1;63(19):6478-87
pubmed: 14559840
Sci Transl Med. 2014 Mar 19;6(228):228ra37
pubmed: 24648340
Cancer Res. 2017 Dec 1;77(23):6667-6678
pubmed: 28993412
Oncotarget. 2015 Sep 8;6(26):21853-64
pubmed: 26392411
Blood. 2019 Feb 7;133(6):588-599
pubmed: 30425048
Cancer Res. 2013 Jan 1;73(1):62-73
pubmed: 23108144
J Immunol. 2001 Oct 1;167(7):4046-50
pubmed: 11564825
J Exp Med. 2014 Mar 10;211(3):563-77
pubmed: 24516120
Oncogene. 2017 Nov 2;36(44):6143-6153
pubmed: 28692048
J Cell Biochem. 2019 Mar;120(3):2756-2765
pubmed: 30270458
Cell. 2019 Apr 18;177(3):556-571.e16
pubmed: 30955881
J Steroid Biochem Mol Biol. 2020 Apr;198:105557
pubmed: 31783150
J Immunol. 2004 Apr 1;172(7):4275-84
pubmed: 15034041
Immunity. 2017 Nov 21;47(5):820-833
pubmed: 29166586
J Exp Med. 2012 Jul 30;209(8):1427-35
pubmed: 22753924
J Immunol. 2016 May 15;196(10):4122-31
pubmed: 27183639
Curr Oncol Rep. 2020 Nov 20;23(1):5
pubmed: 33216252
Cancer Lett. 2017 Dec 28;411:182-190
pubmed: 28947140
J Immunol. 2002 Jun 15;168(12):6494-9
pubmed: 12055270
J Exp Med. 1999 Dec 6;190(11):1669-78
pubmed: 10587357
Int J Cancer. 2015 May 15;136(10):2352-60
pubmed: 25353097
Cancer Immunol Res. 2017 Mar;5(3):248-256
pubmed: 28148545
Cells. 2021 Mar 10;10(3):
pubmed: 33802077
Blood. 2007 Feb 15;109(4):1568-73
pubmed: 17023580
Cells. 2021 Apr 29;10(5):
pubmed: 33946954
Cancer Biol Ther. 2011 Jan 1;11(1):111-21
pubmed: 21099344
Adv Immunol. 2013;120:1-49
pubmed: 24070379
J Clin Pathol. 2015 Mar;68(3):200-5
pubmed: 25477528
Clin Cancer Res. 2020 Jan 15;26(2):344-353
pubmed: 31672767
Commun Biol. 2020 Nov 27;3(1):720
pubmed: 33247183
Cell Mol Immunol. 2017 Oct;14(10):819-829
pubmed: 27321064
Sci Transl Med. 2021 Dec 15;13(624):eabj5070
pubmed: 34910551
Am J Pathol. 2011 Oct;179(4):2131-41
pubmed: 21864492
Annu Rev Immunol. 2022 Apr 26;40:195-220
pubmed: 35044795
Adv Exp Med Biol. 2017;1024:225-244
pubmed: 28921473
Nat Rev Immunol. 2013 Aug;13(8):566-77
pubmed: 23827956
BMC Med. 2016 Feb 06;14:20
pubmed: 26850630
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
Cancer Res. 2003 Dec 15;63(24):8670-3
pubmed: 14695179
Immunogenetics. 2003 Jul;55(4):220-6
pubmed: 12838378
J Immunol Res. 2022 Jan 03;2022:5254911
pubmed: 35028320
J Immunol. 2018 Feb 1;200(3):887-896
pubmed: 29358412
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):718-25
pubmed: 16467081
Science. 2017 Jun 9;356(6342):1072-1076
pubmed: 28495875
Nat Cell Biol. 2016 May;18(5):549-60
pubmed: 27088855
Immunology. 2017 Mar;150(3):265-275
pubmed: 27935637
J Immunol. 2000 Jun 15;164(12):6166-73
pubmed: 10843666
Br J Cancer. 2019 Jan;120(1):16-25
pubmed: 30413826
Cancer Res. 2018 Aug 1;78(15):4253-4269
pubmed: 29789416
Cancer Cell. 2018 Jan 8;33(1):60-74.e6
pubmed: 29316433
Endocr Relat Cancer. 2019 Jan 1;26(1):131-140
pubmed: 30400004
Int J Cancer. 2019 Aug 15;145(4):1099-1110
pubmed: 30671927
Dis Mon. 2022 Mar 17;:101353
pubmed: 35311656
Immunity. 2012 Jul 27;37(1):60-73
pubmed: 22795876
J Clin Invest. 2006 Jul;116(7):1935-45
pubmed: 16778987
Cell. 2008 Oct 3;135(1):37-48
pubmed: 18854153
Vaccines (Basel). 2016 Nov 03;4(4):
pubmed: 27827871
J Exp Med. 2003 Jun 16;197(12):1667-76
pubmed: 12796469
J Immunol. 2014 Apr 15;192(8):3805-15
pubmed: 24646734
Blood Adv. 2019 Nov 26;3(22):3674-3687
pubmed: 31765481
J Cell Physiol. 2019 Apr;234(4):3515-3525
pubmed: 30362521
Nat Immunol. 2022 Mar;23(3):371-379
pubmed: 35228695
J Exp Med. 2022 May 2;219(5):
pubmed: 35348580
Cancer Immunol Res. 2019 Sep;7(9):1535-1546
pubmed: 31311791
Allergy Asthma Proc. 2019 May 1;40(3):138-145
pubmed: 31018888
Cancer Discov. 2020 Aug;10(8):1158-1173
pubmed: 32439653
Nat Immunol. 2018 Feb;19(2):108-119
pubmed: 29348500
Front Immunol. 2019 Jul 31;10:1804
pubmed: 31417568
Blood. 2001 May 15;97(10):3146-51
pubmed: 11342442
Laryngoscope. 2020 Jun;130(6):1496-1502
pubmed: 31508825
J Cell Mol Med. 2018 May;22(5):2706-2716
pubmed: 29473714
Sci Rep. 2019 Mar 14;9(1):4487
pubmed: 30872676
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Cancer Immunol Immunother. 2011 Dec;60(12):1801-10
pubmed: 21811786
Nat Commun. 2017 Jun 06;8:15776
pubmed: 28585539
Clin Immunol. 2013 Oct;149(1):55-64
pubmed: 23891738
J Clin Oncol. 2007 Mar 1;25(7):862-8
pubmed: 17327607
J Allergy Clin Immunol. 2017 Jan;139(1):335-346.e3
pubmed: 27372564
J Clin Invest. 2019 Apr 1;129(4):1441-1451
pubmed: 30932910
Nat Commun. 2017 Nov 10;8(1):1404
pubmed: 29123081
J Clin Invest. 2011 Sep;121(9):3609-22
pubmed: 21841316
J Clin Oncol. 2012 Feb 10;30(5):567-70
pubmed: 22253469
Development. 2019 May 10;146(9):
pubmed: 31076485
Elife. 2021 Feb 08;10:
pubmed: 33554861
Immunity. 2014 Jul 17;41(1):49-61
pubmed: 25035953
Immunity. 2016 Apr 19;44(4):924-38
pubmed: 27096321
J Immunol. 2012 Dec 15;189(12):5602-11
pubmed: 23152559
Cell Mol Immunol. 2021 May;18(5):1290-1304
pubmed: 33239726
Cancer Immunol Res. 2019 Dec;7(12):1928-1943
pubmed: 31530559
J Allergy Clin Immunol. 2016 Nov;138(5):1265-1276
pubmed: 27677386
J Allergy Clin Immunol. 2001 Feb;107(2):258-64
pubmed: 11174191
Oncogene. 2008 Jan 7;27(2):190-9
pubmed: 18176600
Methods Enzymol. 2020;631:329-342
pubmed: 31948555
Mediators Inflamm. 2017;2017:4927964
pubmed: 29138530
Leukemia. 2003 Jun;17(6):1068-77
pubmed: 12764370
Proc Natl Acad Sci U S A. 1986 Aug;83(15):5688-92
pubmed: 2426704
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Clin Exp Immunol. 2020 Apr;200(1):33-44
pubmed: 31784984
Nat Commun. 2014 Dec 04;5:5639
pubmed: 25472612
Int J Cancer. 2014 Apr 1;134(7):1669-82
pubmed: 24105680
Annu Rev Pathol. 2021 Jan 24;16:223-249
pubmed: 33197221
Immunity. 2014 Jan 16;40(1):91-104
pubmed: 24439267
Nat Immunol. 2017 Sep;18(9):1004-1015
pubmed: 28759001
Cancer Res. 2014 Jul 1;74(13):3429-40
pubmed: 24780758
Gut. 2015 Oct;64(10):1593-604
pubmed: 25608525
Cell Rep. 2017 Sep 19;20(12):2891-2905
pubmed: 28930684
Curr Pharm Des. 2003;9(3):257-64
pubmed: 12570830
Oncol Rep. 2021 Mar;45(3):1171-1181
pubmed: 33469683
Int Immunopharmacol. 2018 Oct;63:282-291
pubmed: 30121453
J Exp Med. 2004 May 3;199(9):1213-21
pubmed: 15123743
Nat Biomed Eng. 2018 Aug;2(8):578-588
pubmed: 31015631
Mol Cell Probes. 2020 Apr;50:101498
pubmed: 31891749
Clin Cancer Res. 2017 Sep 15;23(18):5358-5365
pubmed: 28539464
Nat Immunol. 2020 May;21(5):555-566
pubmed: 32327756
J Immunol. 2007 Apr 15;178(8):4947-55
pubmed: 17404276
Cancers (Basel). 2018 Dec 28;11(1):
pubmed: 30597841
Nat Immunol. 2021 Oct;22(10):1256-1267
pubmed: 34462601
Cancer Immunol Res. 2018 Dec;6(12):1548-1560
pubmed: 30282672
Novartis Found Symp. 2006;279:101-9; discussion 109-13, 216-9
pubmed: 17278389
Front Immunol. 2017 Jul 27;8:879
pubmed: 28798749
J Immunol Res. 2020 Jan 13;2020:3948928
pubmed: 32411795
Cancer Discov. 2019 Jun;9(6):711-721
pubmed: 30988166
Oncogene. 2017 Feb 2;36(5):639-651
pubmed: 27345402
EBioMedicine. 2019 Mar;41:333-344
pubmed: 30827928
APMIS. 2009 Dec;117(12):870-9
pubmed: 20078551
Hepatology. 2019 Mar;69(3):1165-1179
pubmed: 30153337
Immunology. 2013 Sep;140(1):22-30
pubmed: 23621371
Eur J Immunol. 2021 Nov;51(11):2568-2575
pubmed: 34347289
Nat Commun. 2016 Aug 30;7:12624
pubmed: 27571927
J Immunol. 2009 Jan 1;182(1):240-9
pubmed: 19109155
J Cell Mol Med. 2018 Feb;22(2):1070-1080
pubmed: 29218828
Exp Dermatol. 2015 Jan;24(1):22-8
pubmed: 25363503
Blood. 2005 Feb 1;105(3):1162-9
pubmed: 15479730
Molecules. 2018 Dec 20;24(1):
pubmed: 30577495
Clin Cancer Res. 2005 Oct 15;11(20):7322-7
pubmed: 16243803
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938
BMC Cancer. 2018 Mar 27;18(1):341
pubmed: 29587679
Cells. 2022 Jan 17;11(2):
pubmed: 35053426
Cancer Immunol Res. 2015 May;3(5):425-35
pubmed: 25941354
Front Immunol. 2019 Sep 24;10:2278
pubmed: 31616440
Oncol Lett. 2017 Mar;13(3):1456-1462
pubmed: 28454277